CCM · Concord Medical Services Holdings Ltd · Financials
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| USD/shares | -$0.10 | -$0.32 | -$3.20 | -$5.40 | — | — | — | — | — | -$2.90 | -$0.90 | $1.50 | — | — | — | — |
| USD/shares | -$0.10 | -$0.32 | -$3.20 | -$5.40 | — | — | — | — | — | -$2.90 | -$0.90 | $1.50 | — | — | — | — |
| shares | 131.05M | 131.05M | 131.05M | 131.05M | 13.11M | 13.11M | 13.02M | 13.01M | 13.01M | 13.06M | 13.45M | 13.48M | 13.51M | 13.82M | 14.23M | 14.6M |
| shares | 131.05M | 131.05M | 131.05M | 131.05M | 13.11M | 13.11M | 13.02M | 13.01M | 13.01M | 13.06M | 13.45M | 13.52M | 13.51M | 13.82M | 14.23M | 14.6M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2018: 183.3M in buybacks, 810.88M in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current debt and lease obligations | 2025-12-31 | CNY 981,064,000 | 20-F filed 2026-04-29 |
| Current debt and lease obligations | 2025-12-31 | USD 140,291,000 | 20-F filed 2026-04-29 |
| Current portion of long-term debt | 2025-12-31 | CNY 550,698,000 | 20-F filed 2026-04-29 |
| Current portion of long-term debt | 2025-12-31 | USD 78,749,000 | 20-F filed 2026-04-29 |
| Noncurrent convertible notes payable | 2025-12-31 | CNY 20,000,000 | 20-F filed 2026-04-29 |
| Noncurrent convertible notes payable | 2025-12-31 | USD 2,860,000 | 20-F filed 2026-04-29 |
| Noncurrent debt carrying amount | 2025-12-31 | CNY 2,465,505,000 | 20-F filed 2026-04-29 |
| Noncurrent debt carrying amount | 2025-12-31 | USD 352,563,000 | 20-F filed 2026-04-29 |
| Noncurrent other long-term debt | 2025-12-31 | CNY 4,134,000 | 20-F filed 2026-04-29 |
| Noncurrent other long-term debt | 2025-12-31 | USD 591,000 | 20-F filed 2026-04-29 |
| Operating lease liabilities | 2025-12-31 | CNY 168,424,000 | 20-F filed 2026-04-29 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Operating lease liabilities | 2025-12-31 | USD 24,084,000 | 20-F filed 2026-04-29 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Other borrowings | 2025-12-31 | CNY 3,384,512,000 | 20-F filed 2026-04-29 |
| Other borrowings | 2025-12-31 | USD 483,980,000 | 20-F filed 2026-04-29 |
| Short-term borrowings | 2025-12-31 | CNY 430,366,000 | 20-F filed 2026-04-29 |
| Short-term borrowings | 2025-12-31 | USD 61,542,000 | 20-F filed 2026-04-29 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 16 similar-size Medical Care Facilities companies (of 56 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (CNY)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Hospital Segment | 373,883,000 | 270,246,000 | 319,059,000 | 217,643,000 | 161,175,000 | 107,052,000 | 76,826,000 | 52,828,000 |
| Network Segment | 86,630,000 | 113,710,000 | 218,343,000 | 254,442,000 | 324,458,000 | 115,959,000 | 121,537,000 | 138,070,000 |
By Geography (CNY)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| China | 472,085,000 | 485,633,000 | 199,370,000 | 164,167,000 | 149,548,000 |
| Singapore | — | — | 23,641,000 | 34,196,000 | 41,350,000 |
By Product & Service (CNY)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Health Care | 294,184,000 | 188,101,000 | 218,595,000 | 131,936,000 | 101,854,000 | 76,997,000 | 54,048,000 | 37,770,000 |
| Medicine Income | 79,699,000 | 82,145,000 | 100,464,000 | 85,707,000 | 59,321,000 | 30,055,000 | 22,777,000 | 15,058,000 |
| Medical Solution | 70,239,000 | 99,158,000 | 178,442,000 | 179,135,000 | 217,375,000 | 26,105,000 | 9,482,000 | 5,867,000 |
| Management and Technical Services | 10,206,000 | 5,196,000 | 23,164,000 | 53,341,000 | 64,599,000 | 36,948,000 | 48,416,000 | 50,291,000 |
| Equipment Leasing Revenues | 6,185,000 | 9,356,000 | 16,737,000 | 21,966,000 | 42,484,000 | 52,906,000 | 58,559,000 | 76,723,000 |
| Royalty | — | — | — | — | — | — | 5,081,000 | 5,189,000 |